Belviq Weight Loss Lawsuit

belviq weight loss drugWeight-loss medicine Belviq has been linked to an increased risk of cancer and has been voluntarily recalled from the U.S. market. Our firm is currently reviewing potential Belviq lawsuits from people who took Belviq or long-acting Belviq XR for an extended time period and have been diagnosed with colorectal, pancreatic, lung or other cancers. Those considering taking legal action may be able seek compensation for their losses.

Let a defective drug lawyer at Gordon & Partners review your situation and discuss your available legal options in a free consultation. You are under no obligation to hire us but if you decide to move forward, we are prepared to help guide you throughout the legal process. For more than two decades, our lawyers have been helping injury victims obtain millions in compensation. Founding member Robert Gordon is AV rated by Martindale-Hubbell, a designation given by peers and clients for the highest level of professional excellence.

We charge no upfront service fees. Call 1 (855) 722-2552 to get started.

Am I Eligible To File a Case?

You can reach out to our legal team in order for us to get a better understanding of your particular circumstances. Things we may ask to assess your eligibility include:

  • Why you were prescribed this medication compared to other weight loss drugs
  • The dosage, whether you were taking the regular tablet or extended-release tablet
  • How long you have been on the weight management medicine
  • Whether you have been diagnosed with cancer by a medical professional and what treatments were ordered
  • Hospitalization required due to serious side effects from taking the drug (cognitive impairment, high levels of serotonin, etc.) or trying to withdraw from the medicine (headache, dizziness, fatigue, etc.)
  • Other damages you have suffered, either physically, emotionally and financially

Holding drug manufacturers liable in defective drug cases can be complex and difficult without having an experienced lawyer to advocate for your rights. We are prepared to answer any questions or concerns you may have about taking legal action during a free and confidential consultation. There is no risk in calling us.

Compensation for Defective Drug Victims

The compensation defective drug victims may be able to recover is determined on a case-by-case basis. We welcome the opportunity to discuss the possible value of your economic and non-economic losses, such as:

  • Expenses from your medical treatment, such as hospital bills, prescription medications, emergency services and rehabilitation costs
  • Loss of wages and earning capabilities from being unable to work or return to work while in recovery
  • Pain and suffering, both physical and mental, from being diagnosed with cancer and undergoing treatments (surgery, radiation and chemotherapy)
  • Loss of enjoyment of life due to the diagnosis and other health complications  

Your medical records along with several other factors can help determine the losses your potential case qualifies for.

Our legal team is standing by to take your call anytime, day or night at 1 (855) 722-2552.

What is Belviq?

Belviq is a weight-loss drug developed by Arena Pharmaceuticals in partnership with Japanese drug maker Eisai Co. Its active ingredient, lorcaserin, affects the chemical signals in the brain that control appetite, making you feel full after eating smaller meals.

Belviq in combination with diet and exercise is used to treat people who are obese or overweight and who may be suffering from type 2 diabetes, high cholesterol or high blood pressure.

The drug was approved by the Food and Drug Administration (FDA) in June of 2012 for chronic weight management. It was the first anti-obesity medication to be approved and marketed since 1999. This is because these drugs have a history of severe and even lethal side effects.

Risks Associated With Taking Belviq

Belviq and Belviq XR have been linked to increasing cancer rates. FDA researchers conducted a clinical trial that involved 12,000 participants over a five-year period to assess the drug’s safety. The study found that those taking the medication over a long period of time had an increased risk of being diagnosed with cancer, including pancreatic, colorectal and lung cancers versus those taking a placebo.

The drug has also been tied to serious health complications. This includes the following:

  • Cognitive impairment – Belviq may cause changes in cognitive function, such as memory loss, attention impairments and confusion. Dizziness or drowsiness from taking the drug could also impair one’s ability to perform daily activities. This is especially true when driving or operating machinery.
  • Psychiatric disorders – People on Belviq may experience hallucinations, euphoria and disassociation. The drug may also cause worsening depression, bipolar symptoms, and severe mood changes.
  • Serotonin syndrome – Belviq is a serotonin stimulant, which may cause serotonin syndrome due to high levels of serotonin in certain areas of the brain. Symptoms could include changes in mental status, blood pressure, high temperature, heart rate or rhythm changes and movement disorders.

Other mild-to-moderate side effects from taking Belviq include:

  • Headache
  • Nausea
  • Fainting
  • Diarrhea
  • Dry mouth
  • Constipation

FDA Belviq Recall Issued

After the study was released, the FDA issued a safety alert on the potential risks of the drug outweighing the benefits and stated that the clinical trial results are ongoing and the exact cause of the cancer is uncertain.

In February of 2020, the FDA in cooperation with Eisai requested the withdrawal of Belviq and Belviq XR from the U.S. market. This included a new safety notification advising people to discontinue taking the medication. Although the drug manufacturer agreed to comply with the agency’s decision to a voluntary recall of the drug, it does not agree with the study’s conclusion linking Belviq use to cancer.

The FDA has advised Belviq users to contact their doctors to discuss alternative medications or weight-loss treatments and that no additional monitoring or testing is required at this time.

Belviq Weight Loss Lawsuits

Former Belviq users may consider filing lawsuits against Eisai Co. over the damages they have experienced. There are many claims former users might make in lawsuits over their injuries, such as:

  • Failing to conduct research on the potential side effects before introducing the drug into the market
  • Ignoring evidence linking Belviq to an increased risk of developing cancer
  • Deceptively marketing and selling the weight-loss drug as being safe and effective
  • Failing to follow up on studies related to Belviq and cancer risks
  • Failing to issue a recall of the drug sooner in an effort to protect profits

Call Gordon & Partners to Discuss a Possible Belviq Recall Lawsuit

Our lawyers at Gordon & Partners are currently reviewing potential Belviq lawsuits if you or someone you know who was taking Belviq or Belviq XR has been diagnosed with pancreatic, colorectal, or lung cancer.

Our consultations are completely free so there is no risk or obligation to take legal action. You may be eligible to recover compensation for your medical expenses, lost wages, and pain and suffering. We are available 24/7 to take your call or chat online. Our firm charges no upfront fees unless we help you obtain a recovery.

Contact our office today at 1 (855) 722-2552 to learn more about your legal options.

For a FREE, no-obligation review of your claim, call us at 1 (855) 722-2552 or complete a Free Case Evaluation form to reach us online

Gordon & Partners - For The Injured®

1 (855) 722-2552

Gordon & Partners, P.A.

4114 Northlake Blvd
Palm Beach Gardens, FL 33410
Phone: 561-333-3333

Gordon & Partners - Plantation

8201 Peters Road, Suite 4000
Plantation, Florida 33324
Phone: 754-333-3333

Gordon & Partners - Stuart

729 SW Federal Highway #212
Stuart, FL 34994
Phone: 772-333-3333